Genetic Risk, CHD Events, and Statin Benefit: Analysis of Prevention Trials | Journal Scan

Study Questions:

Will a composite of genetic variants ascertain the risk of both incident and recurrent coronary heart disease (CHD) events and identify those individuals who derive greater clinical benefit from statin therapy?